NCT01389375

Brief Summary

Are novel vascular closure devices noninferior to manual compression regarding access site complications after coronary angiography?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,524

participants targeted

Target at P75+ for phase_4 coronary-artery-disease

Timeline
Completed

Started Jul 2011

Typical duration for phase_4 coronary-artery-disease

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

July 5, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 8, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

June 10, 2016

Status Verified

July 1, 2014

Enrollment Period

3 years

First QC Date

July 5, 2011

Last Update Submit

June 8, 2016

Conditions

Keywords

Closure DeviceCoronary Angiography

Outcome Measures

Primary Outcomes (1)

  • Composite of arterial access related complications

    Composite of arterial access related complications, defined as the composite of: * Rate of ipsilateral groin hematomas with largest diameter exceeding 5 cm * Pseudoaneurysm * AV-Fistula * Major bleeding * Critical limb ischemia * Local infection * Surgical repair * Revascularisation

    30 days

Secondary Outcomes (4)

  • Time to hemostasis, from sheath removal to complete hemostasis

    30 days

  • Device deployment failure

    30 days

  • Need for repeated manual compression after end of closure procedure

    30 days

  • Cost-benefit Analysis

    30 days

Study Arms (3)

FemoSeal®

EXPERIMENTAL

Device: FemoSeal®

Device: FemoSeal®

ExoSeal®

EXPERIMENTAL

Device: ExoSeal®

Device: ExoSeal®

Manual compression

ACTIVE COMPARATOR

Other: Manual compression

Other: Manual compression

Interventions

Closure device for femoral artery access closure

FemoSeal®
ExoSeal®DEVICE

Closure device for femoral artery access closure

ExoSeal®

Conventional manual compression

Manual compression

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient between 18 and 85 years of age
  • Patients undergoing femoral access coronary angiography
  • Access only with 6 F sheath
  • Patient must be competent for providing informed written consent

You may not qualify if:

  • Peripheral arterial occlusive disease
  • Prior peripheral artery surgery
  • Percutaneous coronary intervention
  • Femoral access device closure in last 30 days
  • Scheduled Coronary Angiography/Intervention within 90 days
  • Critical limb ischemic
  • Uncontrolled hypertension \>220/110 mmHg
  • Coagulopathy (bleeding disorder)
  • Local infection
  • Common femoral artery lumen diameter \< 5 mm
  • Allergy to absorbable suture
  • Autoimmune Disease
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Deutsches Herzzentrum Muenchen

Munich, 80636, Germany

Location

Klinikum rechts der Isar

Munich, 81675, Germany

Location

Related Publications (3)

  • Schulz-Schupke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, Hoppe K, Bottiger C, Groha P, Bradaric C, Schmidt R, Bott-Flugel L, Ott I, Goedel J, Byrne RA, Schneider S, Burgdorf C, Morath T, Kufner S, Joner M, Cassese S, Hoppmann P, Hengstenberg C, Pache J, Fusaro M, Massberg S, Mehilli J, Schunkert H, Laugwitz KL, Kastrati A; Instrumental Sealing of Arterial Puncture Site-CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA. 2014 Nov 19;312(19):1981-7. doi: 10.1001/jama.2014.15305.

    PMID: 25399273BACKGROUND
  • Gewalt SM, Helde SM, Ibrahim T, Mayer K, Schmidt R, Bott-Flugel L, Hoppe K, Ott I, Hieber J, Morath T, Byrne RA, Kufner S, Cassese S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Schupke S; Instrumental Sealing of Arterial Puncture Site-CLOSURE Device Versus Manual Compression (ISAR-CLOSURE) Trial Investigators. Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women. Circ Cardiovasc Interv. 2018 Aug;11(8):e006074. doi: 10.1161/CIRCINTERVENTIONS.117.006074.

  • Xhepa E, Byrne RA, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Bottiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz KL, Kastrati A; ISAR-CLOSURE investigators. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial. EuroIntervention. 2014 Jun;10(2):198-203. doi: 10.4244/EIJV10I2A33.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Maryam Linhardt, MD

    Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2011

First Posted

July 8, 2011

Study Start

July 1, 2011

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

June 10, 2016

Record last verified: 2014-07

Locations